KA Medical
Zinzino Independent Partner
Benvenuto! Sono il suo consulente indipendente, qui per guidarla nel suo percorso di salute.
Investor relations
Financial calendar
Zinzino Bokslutskommuniké 2024
Zinzino Year-End Report 2024
Annualreport 2024
Årsredovisning 2024
Financial reports
Press releases
ZINZINO AB (PUBL): Zinzino announces Canary Islands as next step in its global expansion
mercoledì 13 novembre 2024 15:00
ApriZINZINO AB (PUBL): Share subscription due to directed set-off issues
giovedì 19 settembre 2024 15:30
ApriZINZINO AB (PUBL.): ZINZINO ACQUIRES 49% OF CYPRIOT OLIVE OIL PRODUCER CLEANTHI ALPHA-OLENIC LTD
giovedì 27 giugno 2024 11:00
ApriZINZINO AB (PUBL): LETTER OF INTENT TO ACQUIRE ZURVITA INCREASES DISTRIBUTION POWER IN NORTH AMERICA
lunedì 17 giugno 2024 11:00
ApriZINZINO AB (PUBL): Zinzino announces Serbia as next step in its global expansion
martedì 11 giugno 2024 15:30
ApriZINZINO AB (PUBL): Zinzino now seeks acquisitions in the US and Asia to increase distribution power
venerdì 7 giugno 2024 12:00
ApriZINZINO AB (PUBL): Zinzino acquires assets in Xelliss – strategic reinforcement in southern Europe and in the microalgae spirulina
domenica 12 maggio 2024 13:00
ApriZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024
venerdì 26 aprile 2024 08:00
ApriZINZINO AB (PUBL): Zinzino and ACN, enter a strategic partnership in Europe, and in connection with it Zinzino carries out a directed new issue of B shares for SEK 10.4 million.
lunedì 29 gennaio 2024 10:00
ApriZINZINO AB (PUBL): Zinzino changes Certified Adviser to Carnegie Investment Bank AB (publ)
giovedì 30 novembre 2023 09:00
ApriZINZINO AB (PUBL): Zinzino announces Mexico as next step in its global expansion
venerdì 22 settembre 2023 08:00
ApriZINZINO AB (PUBL.): NOTICE TO THE ANNUAL MEETING OF ZINZINO AB ON MAY 31, 2023
martedì 2 maggio 2023 08:00
ApriZINZINO AB (PUBL): Zinzino launches Turkey as a next market on their road towards global expansion
martedì 7 marzo 2023 14:30
ApriGrowing interest in personal health and customized supplements can be a great investment case
lunedì 28 novembre 2022 14:30
ApriZINZINO AB (PUBL): Share subscription due to directed offset issue
mercoledì 26 ottobre 2022 16:30
ApriZinzino announces the launch of Singapore as next step in their global expansion
giovedì 7 aprile 2022 11:30
ApriZINZINO AB (PUBL): Zinzino acquires brand portfolio with Swiss skincare and supplements
mercoledì 6 aprile 2022 09:30
ApriZINZINO AB (PUBL): MEMBERS OF THE NOMINATION COMMITTEE FOR ZINZINO AB'S ANNUAL GENERAL MEETING IN 2022
giovedì 18 novembre 2021 14:00
ApriZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion
martedì 9 novembre 2021 11:30
ApriZINZINO AB (PUBL): Zinzino announces launch of Taiwan as next step in the global expansion
giovedì 9 settembre 2021 13:00
ApriZINZINO AB (PUBL): Zinzino announces the launch of Malaysia as next step in their global expansion
giovedì 3 giugno 2021 11:00
ApriZINZINO AB (PUBL): A new signature BalanceOil from the pioneers of test-based nutrition
giovedì 15 aprile 2021 15:00
ApriZINZINO AB (PUBL): Zinzino announces the launch of India as next step in their global expansion strategy
martedì 6 aprile 2021 14:00
ApriZINZINO AB (PUBL): Further expansions of the Zinzino global web shop
martedì 15 dicembre 2020 16:15
ApriZINZINO AB (PUBL): ZINZINO MOVES TO THE PREMIER SEGMENT OF FIRST NORTH GROWTH MARKET
mercoledì 16 settembre 2020 10:00
ApriZINZINO AB (PUBL): ONE-TIME EFFECT DUE TO CHANGED ACCOUNTING FOR DISTRIBUTOR REMUNERATION IMPROVES Q1 2020 WITH SEK 22.2 MILLION BEFORE TAX
martedì 5 maggio 2020 12:00
ApriZINZINO AB (PUBL): Zinzino and Life Leadership collaborate to provide test-based nutrition to expanding markets
venerdì 25 ottobre 2019 16:40
ApriZINZINO AB (PUBL): THE BOARD DECIDES TO ISSUE 200 000 STOCK OPTIONS
lunedì 15 ottobre 2018 15:00
ApriZINZINO AB (PUBL.) APPOINTED “GROWTH COMPANY OF THE YEAR 2017” BY DIRECT SELLING SWEDEN
venerdì 1 giugno 2018 11:00
ApriZINZINO AB (PUBL): Q1; CONTINUED SOUND GROWTH AND STRONG PROFITABILITY IMPROVEMENT, EBITDA RISING BY 45%
martedì 15 maggio 2018 08:00
ApriZINZINO AB (PUBL): STRONG GROWTH AND PROPOSAL FOR GREATLY INCREASED DIVIDENDS
mercoledì 28 febbraio 2018 08:00
ApriZINZINO AB (PUBL): PRELIMINARY SALES REPORT FOR Q4 AND 2017 WITH PROPOSAL TO INCREASE DIVIDEND
venerdì 19 gennaio 2018 18:00
ApriInterim report, July – September 2017: IMPROVED GROSS MARGINS AND STRONG GROWTH IN THE DOMESTIC MARKET.
lunedì 13 novembre 2017 08:30
ApriZinzino launches groundbreaking product: BalanceOil Vegan for the heart and brain
venerdì 20 ottobre 2017 13:00
ApriZINZINO AB (PUBL): CORRECTION: PRELIMINARY SALES REPORT THIRD QUARTER 2017
martedì 10 ottobre 2017 17:00
ApriInterim Report, Zinzino, April – June 2017: Very strong growth of 28% and full-scale launch of a new digital platform
giovedì 31 agosto 2017 09:00
ApriZINZINO LAUNCHES VIVA, A NEW DIETARY SUPPLEMENT PROMOTING BETTER SLEEP, REDUCING STRESS AND INCREASING WELL-BEING
venerdì 30 giugno 2017 15:00
ApriZinzino AB (publ.) appointed “Growth Company of the Year 2016” in direct sales
venerdì 2 giugno 2017 16:00
ApriZinzino begins selling in Switzerland ”Rich in capital and an important market”
martedì 16 maggio 2017 16:00
ApriInterim Report, January – March 2017: Zinzino continues to deliver strong growth and is well prepared for increased profitability
mercoledì 10 maggio 2017 09:00
ApriZinzino taking the Omega-6/Omega-3 concept to new heights with water-miscible AquaX oil
giovedì 7 luglio 2016 16:24
ApriZinzino expands sales to all EU countries “We see a huge potential”
martedì 5 luglio 2016 11:10
ApriYear-End Report 1st January - 31st December 2015, Zinzino AB (publ)
lunedì 29 febbraio 2016 11:53
ApriSweden's Zinzino is improving its foothold in Europe – with the establishment of operations in Germany
lunedì 22 febbraio 2016 08:00
ApriZinzino launches Zinzino LeanShake – a nutritious meal replacement for weight control
venerdì 11 dicembre 2015 11:58
ApriSwedish Zinzino continues to grow internationally with its establishment in Canada
giovedì 17 settembre 2015 09:28
ApriZinzino AB (publ) acquires further 13.8 per cent of Faun Pharma AS – safeguarding continued research and expanded product range
venerdì 6 marzo 2015 10:29
ApriFinancial Statements 1 January - 31 December 2014, Zinzino AB (publ)
venerdì 27 febbraio 2015 14:39
ApriThe stock
Sustainability Report
Read more about our sustainability approach, targets and 2023 performance.
Greta Billing
shares@zinzino.com
+46 73 627 17 54
Fredrik Nielsen
shares@zinzino.com
+46 (0)707 900 174
Certified Adviser
All companies whose shares are to be traded on the Nasdaq First North Premier Growth Market have a certified adviser who guides and supports the company through the listing process. Subsequently, the adviser monitors that the company complies with First North's regulations for providing information to the market and investors. Carnegie Investment Bank AB (publ) is the Certified Adviser for Zinzino AB.
Certified Adviser:
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se
Why invest in Zinzino
A clear global strategy with a growth-driven, future-proof business model
Zinzino is one of Europe’s fastest-growing direct sales companies with an aggressive global expansion strategy. The Scandinavian-based health tech company is currently operating in Europe, North America, Asia, Australia, India and Africa. The overall company strategy and business model is to achieve profitable growth in new as well as existing markets. The massive growth momentum of the past decade is expected to stay constant thanks to the stability and structure of the business model in combination with top-of-the-line digital market tools as well as continuous company acquisitions.
Help improve the health of the world
Our product concept is to give health back to the world. Our goal is to get the best out of people with enthusiasm, encouragement and a great deal of energy. We are the most customer-focused direct sales company in the world. Our most important product concept, Balance, is showing continued good growth and we currently have over 500,000 test results based on blood tests in our database. We are the company that has done the most fatty acid analyses in the world.
Product development at the leading edge
Through efficient product development in-house, the company has developed a number of new products in health in which it owns its own important intellectual property rights. The newly developed products are manufactured in our own efficient production facility which means that we have 100% quality control. Zinzino’s strategy in the coming years includes continued product development at the leading edge.
Strong market position and distribution
Zinzino has strong sales organisations in its principal markets with good relationships with its customer base. The broad product portfolio attracts new customer groups and thereby generates growth. Through an updated IT platform and logistics system, Zinzino is well equipped for the expected sales growth in the coming years.
Attractive cash flow enables increased stock dividends and gives a good direct return
Zinzino’s business has a very strong cash-generating capability. Effective management of working capital combined with investments that quickly generate revenue and marginal improvements generate a strong cash flow. Thus, dividends can be distributed in accordance with the target of at least 50 per cent of the free cash flow.
Condividi questa pagina
O copia il link